Cargando…
Epigenetic alterations leading to TMPRSS4 promoter hypomethylation and protein overexpression predict poor prognosis in squamous lung cancer patients
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related death worldwide, which highlights the need of innovative therapeutic options. Although targeted therapies can be successfully used in a subset of patients with lung adenocarcinomas (ADC), they are not appropriate for patients...
Autores principales: | Villalba, Maria, Diaz-Lagares, Angel, Redrado, Miriam, de Aberasturi, Arrate L., Segura, Victor, Bodegas, Maria Elena, Pajares, Maria J., Pio, Ruben, Freire, Javier, Gomez-Roman, Javier, Montuenga, Luis M., Esteller, Manel, Sandoval, Juan, Calvo, Alfonso |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008398/ https://www.ncbi.nlm.nih.gov/pubmed/26989022 http://dx.doi.org/10.18632/oncotarget.8045 |
Ejemplares similares
-
TMPRSS4 regulates levels of integrin α5 in NSCLC through miR-205 activity to promote metastasis
por: Larzabal, L, et al.
Publicado: (2014) -
Identification of a novel synthetic lethal vulnerability in non-small cell lung cancer by co-targeting TMPRSS4 and DDR1
por: Villalba, Maria, et al.
Publicado: (2019) -
TMPRSS4: A Novel Tumor Prognostic Indicator for the Stratification of Stage IA Tumors and a Liquid Biopsy Biomarker for NSCLC Patients
por: Villalba, Maria, et al.
Publicado: (2019) -
Overexpression of TMPRSS4 in non-small cell lung cancer is associated with poor prognosis in patients with squamous histology
por: Larzabal, L, et al.
Publicado: (2011) -
TMPRSS4: an emerging potential therapeutic target in cancer
por: de Aberasturi, A L, et al.
Publicado: (2015)